The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
If it wasn’t already, biotech’s pandemic IPO boom is in full swing.
After a week that saw the largest Chinese biotech IPO in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
